These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 3057938)

  • 1. Intranasal administration of dantrolene increased brain concentration and duration.
    Wang J; Shi Y; Yu S; Wang Y; Meng Q; Liang G; Eckenhoff MF; Wei H
    PLoS One; 2020; 15(3):e0229156. PubMed ID: 32160210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current clinical application of dantrolene sodium.
    Yang HS; Choi JM; In J; Sung TY; Kim YB; Sultana S
    Anesth Pain Med (Seoul); 2023 Jul; 18(3):220-232. PubMed ID: 37691593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repurposing Dantrolene for Long-Term Combination Therapy to Potentiate Antisense-Mediated DMD Exon Skipping in the mdx Mouse.
    Wang DW; Mokhonova EI; Kendall GC; Becerra D; Naeini YB; Cantor RM; Spencer MJ; Nelson SF; Miceli MC
    Mol Ther Nucleic Acids; 2018 Jun; 11():180-191. PubMed ID: 29858053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JSA guideline for the management of malignant hyperthermia crisis 2016.
    Safety Committee of Japanese Society of Anesthesiologists
    J Anesth; 2017 Apr; 31(2):307-317. PubMed ID: 28246924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rare postoperative delayed malignant hyperthermia after off-pump coronary bypass surgery and brief review of literature.
    Raut MS; Kar S; Maheshwari A; Shivnani G; Kumar A; Daniel E; Joshi S; Motihar A; Gupta P
    Ann Card Anaesth; 2016; 19(2):357-62. PubMed ID: 27052086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of long-term oral dantrolene on the neuromuscular action of rocuronium: a case report.
    Jeon J; Song S; Kim MC; Kim KM; Lee S
    Korean J Anesthesiol; 2014 Feb; 66(2):153-6. PubMed ID: 24624274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic evaluation of oral dantrolene in the dog.
    Haraschak JL; Langston VC; Wang R; Riggs C; Fellman C; Ross MK; Bulla C; Lunsford K; Mackin A; Archer T
    J Vet Pharmacol Ther; 2014 Jun; 37(3):286-94. PubMed ID: 24219828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A suspected case of malignant hyperthermia that was successfully treated with dantrolene administration via nasogastric tube.
    Kang BJ; Song J; Kim SK; Yoo JH
    Korean J Anesthesiol; 2012 Oct; 63(4):378-80. PubMed ID: 23115697
    [No Abstract]   [Full Text] [Related]  

  • 9. Complications associated with the administration of dantrolene 1987 to 2006: a report from the North American Malignant Hyperthermia Registry of the Malignant Hyperthermia Association of the United States.
    Brandom BW; Larach MG; Chen MS; Young MC
    Anesth Analg; 2011 May; 112(5):1115-23. PubMed ID: 21372281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dantrolene reduces the threshold and gain for shivering.
    Lin CM; Neeru S; Doufas AG; Liem E; Muneer Shah Y; Wadhwa A; Lenhardt R; Bjorksten A; Taguchi A; Kabon B; Sessler DI; Kurz A
    Anesth Analg; 2004 May; 98(5):1318-24, table of contents. PubMed ID: 15105208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant hyperthermia after oral and intravenous pretreatment with dantrolene in a patient susceptible to malignant hyperthermia.
    Ruhland G; Hinkle AJ
    Anesthesiology; 1984 Feb; 60(2):159-60. PubMed ID: 6696240
    [No Abstract]   [Full Text] [Related]  

  • 12. Malignant hyperthermia susceptibility--successful management with a "stressfree" technique.
    Jantzen JP; Erdmann K; Kleemann PP
    Acta Anaesthesiol Belg; 1987; 38(1):107-13. PubMed ID: 3591264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [An attempt to reconcile differences of opinion in the field of malignant hyperthermia].
    Schulte-Sasse U; Eberlein HJ
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1991 Dec; 26(8):464-7. PubMed ID: 1786307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity.
    Ward A; Chaffman MO; Sorkin EM
    Drugs; 1986 Aug; 32(2):130-68. PubMed ID: 3527659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma levels of dantrolene following oral administration in malignant hyperthermia-susceptible patients.
    Allen GC; Cattran CB; Peterson RG; Lalande M
    Anesthesiology; 1988 Dec; 69(6):900-4. PubMed ID: 3057938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of intravenous dantrolene in children.
    Lerman J; McLeod ME; Strong HA
    Anesthesiology; 1989 Apr; 70(4):625-9. PubMed ID: 2929999
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.